Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Ziopharm Oncology buy exploration

Start price
€7.12
22.04.16 / 50%
Target price
€10.10
19.07.16
Performance (%)
-43.45%
End price
€4.03
19.07.16
Summary
This prediction ended on 19.07.16 with a price of €4.03. The BUY prediction by exploration for Ziopharm Oncology performed very badly with a performance of -43.45%. exploration has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Ziopharm Oncology - - - -
iShares Core DAX® 1.776% 3.175% 14.882% 17.660%
iShares Nasdaq 100 -1.037% 1.869% 35.463% 52.324%
iShares Nikkei 225® -0.335% 3.857% 14.485% 11.459%
iShares S&P 500 0.854% 2.567% 31.105% 47.441%

Comments by exploration for this prediction

In the thread Ziopharm Oncology diskutieren
Prediction Buy
Perf. (%) -43.45%
Target price 10.102
Change
Ends at 19.07.16

Ziopharm: Biotechwerte werden wieder interessant

langfristig werden auch Biotechwerte wieder interessant.

Prediction Buy
Perf. (%) -43.45%
Target price 10.102
Change
Ends at 19.07.16

(Stop Loss Kurs erreicht)